-
Mashup Score: 0BLA for Subcutaneous Nivolumab Accepted by the FDA for Advanced/Metastatic Solid Tumors - 14 hour(s) ago
A biologics license application has been accepted by the FDA for subcutaneous nivolumab to treat adult patients eligible for approved solid tumor nivolumab indications
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Enzalutamide with and without leuprolide improves rates of undetectable PSA levels compared with leuprolide alone in castration-sensitive prostate cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Second-line venetoclax may lead to monthly cost savings vs second-line BTK inhibitor for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Approves Tarlatamab for Extensive-Stage SCLC - 2 day(s) ago
Tarlatamab, a bispecific T-cell engager, was approved by the FDA for adults with extensive-stage small cell lung cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Tolerable anti-tumor activity was demonstrated in patients with HER2-overexpressing non–small cell lung cancer who were treated with trastuzumab deruxtecan at 2 dose levels.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Frontline treatment with pembrolizumab plus trastuzumab/chemotherapy significantly and meaningfully improved overall survival in HER2-positive, unresectable or metastatic gastric/GEJ cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8
An expert explained the importance of having strong communication skills not only for all patients with cancer, but especially for those who received a terminal diagnosis.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Lisocabtagene maraleucel was approved by the FDA to treat adults with relapsed/refractory follicular lymphoma who were treated with 2 or more prior lines of systemic therapy.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
One of the first HPV self-collection solutions has been approved by the FDA, which can identify women at risk of developing cervical cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Recent data from a phase 3b trial support venetoclax as a CLL treatment option for those with or without B-cell receptor–associated kinase inhibitor treatment.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
A biologics license application has been accepted by the FDA for subcutaneous nivolumab to treat adult patients eligible for approved solid tumor nivolumab indications https://t.co/LkMkLTOLaU